Roche

AbbVie, Roche's Venclexta endangers AML approval with flopped confirmatory trial
Fierce Pharma
Mon, 03/2/20 - 11:07 pm
AbbVie
Roche
Venclexta
AML
blood cancer
FDA
U.K. Regulatory Advisor Rejects Roche Cancer Drug
Motley Fool
Wed, 02/26/20 - 11:23 pm
Roche
UK
NICE
Polivy
cancer
Kahr raises $18M to test CD47 drug with Roche's Tecentriq
Fierce Biotech
Tue, 02/25/20 - 10:24 am
Kahr Medical
anti-CD47
Roche
Tecentriq
Genentech pays Bicycle $30M upfront to form discovery-stage immuno-oncology pact
Fierce Biotech
Tue, 02/25/20 - 10:18 am
Roche
Genentech
Bicycle Therapeutics
R&D
immuno-oncology
FDA Grants Priority Review to Roche's Lung Cancer Drug Tecentriq
Motley Fool
Thu, 02/20/20 - 10:44 am
Roche
FDA
priority review
Tecentriq
non-squamous non-small cell lung cancer
non-small cell lung cancer
A blockbuster breast cancer niche has Roche and Sanofi in the lead
EP Vantage
Wed, 02/19/20 - 11:33 pm
Sanofi
Roche
SAR439859
RG6171
clinical trials
Serds
breast cancer
Roche gets Chinese approval for Tecentriq plus chemotherapy to treat ES-SCLC
Pharmaceutical Business Review
Fri, 02/14/20 - 10:36 am
Roche
China
NMPA
Tecentriq
extensive-stage small cell lung cancer
Catching up with Roche, Merck racks up positive data in frontline triple negative breast cancer
Endpoints
Wed, 02/12/20 - 10:55 am
Merck
Keytruda
triple negative breast cancer
clinical trials
Roche
Ligand snags Roche-partnered drug in Icagen buyout
Fierce Biotech
Wed, 02/12/20 - 10:46 am
Ligand Pharmaceuticals
Roche
Icagen
M&A
Perioperative use proves elusive for Tecentriq
EP Vantage
Tue, 02/11/20 - 10:40 am
Roche
Tecentriq
Lilly and Roche's antibodies fail late-phase Alzheimer's test
Fierce Biotech
Mon, 02/10/20 - 10:17 am
Eli Lilly
Roche
Alzheimer's disease
clinical trials
solanezumab
gantenerumab
Roche’s gantenerumab fails to meet primary endpoint in AD trial
Pharmaceutical Business Review
Mon, 02/10/20 - 10:08 am
Roche
gantenerumab
Alzheimer's disease
clinical trials
Roche posts data on SMA rival to drugs from Biogen, Novartis
Fierce Biotech
Thu, 02/6/20 - 10:53 am
Roche
SMA
FDA
risdiplam
Bio-Thera Solutions announces positive top-line results for BAT1706, a proposed biosimilar to Avastin
Pharmaceutical Business Review
Tue, 02/4/20 - 10:05 am
BAT1706
Bio-Thera Solutions
Avastin
Roche
non-squamous non-small cell lung cancer
biosimilars
3 Big Drugmakers Are Taking On the Coronavirus
Motley Fool
Mon, 02/3/20 - 10:32 am
Gilead Sciences
Moderna Therapeutics
Roche
Wuhan Coronavirus
China
Amgen, Pfizer biosimilar sales pressure top drugs
BioPharma Dive
Fri, 01/31/20 - 12:13 pm
biosimilars
Amgen
Pfizer
Roche
Roche’s next immuno-oncology combo is a big bet on Tigit
EP Vantage
Fri, 01/31/20 - 10:47 am
Roche
immuno-oncology
Tigit
Roche fights off biosimilar competition as new medicines' sales soar
Pharmaforum
Thu, 01/30/20 - 10:54 am
Roche
biosimilars
earnings
Pfizer launches biosimilars to Roche’s ‘big three’ cancer drugs in US
Pharmaforum
Fri, 01/24/20 - 10:11 am
Pfizer
Roche
biosimilars
Avastin
Zirabev
Herceptin
Trazimera
Rituxan
Ruxience
Roche's Tecentriq fails trial in form of urothelial cancer
Reuters
Fri, 01/24/20 - 10:08 am
Roche
Genentech
clinical trials
Tecentriq
urothelial cancer
bladder cancer

Pages